Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors

Clinical trial NCT00054977 · COMPLETED

Trial details

NCT number: NCT00054977
Sponsor: Galectin Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Lung Cancer Breast Cancer Head and Neck Cancer Prostate Cancer

Start date: 2003-02-01
Primary completion: 2005-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.